-I have been investing since the fall of 2008 and invested through one of the most difficult investing periods in history and know the importance of dividend growth and stability during those times as well as during the good times. I started writing for Seeking Alpha a little over three years ago and I have been successful with the companies I write about, which is shown by my high TipRanks success rate (Link Below). https://www.tipranks.com/bloggers/brad-kenagy
Researcher, Portfolio Manager, Financial Advisor, and Educator
I am currently an educator and portfolio manager for Marketocracy, and manage the Hybrid Fund, which invests in a mix of stocks and bond ETFs. This aggressive portfolio emphasizes stocks, with a target allocation of 80% equities. To achieve this target allocation, an equal balance between Large Cap, Mid Cap, Small Cap, and ADRs is sought.
Criteria for stock selection includes financially strong companies, with high liquidity, and growth at a reasonable price.
Given the current interest rate environment, intermediate bond ETFs are given preference.
Retired, late 50's
Hold CFP designation. Passed CFP exam Nov 2000
Author of "IRA: A Quck Reference Guide". Available on Amazon as an e-book.
Author of "Retirement Investing for INCOME ONLY: How to invest for relaible income in Retirement ONLY from Dividends"
Christopher G.DeMaria is a member of the Global Community. Having lived abroad for more than 18 years, he studied in South America, Europe, Southeast Asia and the United States. Chris is the owner of DeMaria Financial Services and an Investment Advisor Representative with Kovack Investment Advisors, Inc. He began his career in financial planning and portfolio management in March of 1998 after earning a degree from Ohio University where he majored in Economics and minored in Business Administration.
Chris focuses on achieving "positive" results regardless of how the market indices perform. Unlike some managers, Chris manages the risk of each individual portfolio rather than remaining invested at all times. Chris strives to identify low risk entry points and conversely, uses a calculated exit strategy when market risk is high or positions are lagging or down. Chris does not try to beat an index every quarter. Instead, he is focused on the potential for low risk profits. If you manage risk well and avoid large corrections, you will naturally create much better results.
There is no new thing under the sun Ecc 1:9
The headlines in the news change daily and market leaders change regularly but, the one thing that remains consistent over time is how humans react to stock market volatility (aka fear and greed). During highly volatile markets and market inflection points, human emotion is a consistent and measurable phenomenon that generally isn’t accounted for in any research report or stock analysis. This observation precipitated the creation of the proprietary market risk meter for quantifying said human emotion and consequent reactions to short term market activity. Regardless of education, wealth, knowledge, or any other factor that may make a person seem wise, people react the same way when fear or greed sets in. No matter how many times a fire drill is rehearsed, when an emergency presents itself, the exit is often not pleasant.
This methodology is by no means perfect however, it is a best effort attempt to quantify the belief that many things will return to some sort of mean over time and that people consistently exhibit the same undulating responses to fear and greed. Consequently, it is possible to view the ebbs and flows of the markets as ocean tides. When the tide comes in, risk is higher and conversely, when the tide flows out, risk is lower. Although it is not possible to consistently predict exactly when a correction or bounce will occur, it is possible to determine when a change in trend is occurring. Furthermore, a sophisticated investor can often determine when there is more or less inherent risk in the market. It is also possible to examine whether the tide has come in further than normal, presenting greater risk or gone out further than normal, providing a rare lower-risk entry point.
When risk is elevated, active investors should begin trimming losers, laggards, and potentially take partial gains from winners in portfolios. Investors may also consider reviewing the types of positions worth holding when things get ugly. Long-term asset allocation investors can look at re-balancing portfolios by shifting equity gains to other less market correlated asset classes like bonds or cash alternatives. Some investors may also consider hedging strategies like selling calls, purchasing puts, or stop limit orders to try to mitigate risk.
Conversely, when risk is lower, a plan of action should already be in place with a buy list of favored mutual funds, equities, and ETF's having been identified. Secondly, it is essential to identify a high volume, high volatility, downside trading day that is coupled with a strong reversal and 1-2 days' follow through. When all of these conditions are met, this methodology recommends purchasing equities.
Methodology for determining favored sectors
Christopher G. DeMaria has over 18 years of experience managing money for individuals, corporations, and foundations. While adapting from successes and failures throughout some of the most challenging markets since the Great Depression (1998 to 2016), his methodology has been continuously tested over that time in order to improve its reliability and effectiveness.
Part of his investment methodology includes a quantitative approach to identifying changes in trends at early stages and continually monitoring their relative performance against one-another. This process uses simple mathematical ratios (IE: SPY /EFA or SPY/XLB) to determine when one asset class is performing better than another. When properly calibrated, these ratios provide a precise moment when the trend in one asset changes compared to another.
This process is most effective when portfolio holdings are methodically adjusted based on different levels of market risk and relative asset class performance. As stated above, when risk is higher, portfolio holdings should be reallocated out of lagging or losing asset classes and moved into leading, lower risk, or non-market correlated assets. This process inherently frees up cash for future “lower risk entry points” when assets can be allocated
back into equities and other favored assets. Essentially this is a systematic approach designed to attempt to purchase leading asset classes when market risk is lower and sell lagging and losing positions when market risk is higher. In the end, the goal is to buy low and sell high.
There are three key factors to successfully implementing this portfolio management process. The first is having sufficient knowledge and understanding of the financial markets which takes time to acquire. The second is having adequate time and dedication to develop skill. The third is having the proper discipline to continually monitor the process. Many individuals have some or even all of these characteristics but, simply lack the time, interest, or expertise to dedicate themselves to managing their own portfolios properly. With the exception of those whom are confident in their knowledge, skill, and discipline to manage this process, it is strongly advised to seek professional assistance.
This Risk Managed Global Sector Rotation strategy has been well documented on Seeking Alpha during the most recent correction. Furthermore, a full cycle from high risk to low risk and subsequent recovery was well documented on Seeking Alpha in 2014.
The Lows Still Appear To Be In...What's Next?
Wed, Feb. 24th, 2016 (confirming successful retest of lows and providing actionable ideas)
Weekly Leading Sectors Report
Wed, Feb. 10th, 2016 (confirminglows and providing actionable ideas)
In Hoc Signo Vinces... What Market Signs Are You Watching?
Fri, Feb. 5th, 2016 (confirming lows and providing a macroeconomic overview)
The Lows Appear To Be In... What's Next?
Tue, Jan. 26 (confirming lows and providing actionable ideas)
How Can You Identify Market Turning Points?... Reloaded
Thu, Jan. 21 (identifying lows, Dow Theory discussion and providing actionable ideas)
2014 Full Cycle
This Looks Like The Lower-Risk Buying Opportunity We've Been Waiting For
Oct. 24th, 2014 (identifying lows and providing actionable ideas)
Preparing For A Lower-Risk Entry Point In A Secular Bull Market
Oct. 13th, 2014(preparing for the lows and providing actionable ideas)
The Quiet Before The Little Storm
Jul. 8th, 2014 (warning about higher risk and preparing for volatility and short term correction)
How Can You Adjust Your Investment Strategy To Enhance Returns?
May 28th, 2014 (explanation of a possible long term secular bull market and actionable ideas)
PhD - A Real Value Risk Estimation Model for an Emerging Market
Investment manager at Let it grow investments, Netherlands
Finance lecturer at the University of applied sciences Amsterdam, Netherlands
Data researcher at Bloomberg, London UK
Founder of "The Contrarian", a premium research service, featuring the "Bet The Farm" Portfolio. Actively investing since 1995, I have soared like an eagle, and been unmercifully humbled by the markets. Achieved positive returns in 2008, and turned an account with $60,310 on 1/1/2009 into an account with $3,177,937 on 11/30/2009. My best years have been 1995-2003, 2008-2012, and 2016-????. My worst years were 2013-2015. I believe inflation is coming, and we are at an inflection point in the markets.
Twenty year career as an investment analyst, investor, portfolio manager, consultant, and writer. Founder of Koldus Contrarian Investments, Ltd, which was incorporated in the spring of 2009. Dyed in the wool contrarian investor, who has learned, the hard way, that a good contrarian is only contrarian 20% of the time, but being right at key inflection points is the key to meaningful wealth creation in the markets. I believe we are near a meaningful inflection point, perhaps the biggest one yet, for the third time in the past 15 years.
Historically, I have had huge wins and impressive losses based on a concentrated, contrarian strategy. Trying to keep the good while filtering out the bad.
Seeking to run an all weather portfolio with minimal volatility and index overlays to capture my strategic and tactical recommendations along with a concentrated best ideas portfolio, which is my bread and butter, but the volatility only makes it suitable for a small piece of an investor's overall portfolio. The following are a couple of my favorite investment quotes.
"Life and investing are long ballgames." Julian Robertson
"A diamond is a chunk of coal that is made good under pressure."
"Knowledge is limited. Imagination encircles the world." Albert Einstein
I’ve been on top of the world, and the world has been on top of me. I have learned to enjoy the perspective from each view, and use opportunities to persistently acquire knowledge, and enjoy the company of those around me, especially loved ones, family, and friends.
At heart, I am a market historian with an unrivaled passion for the capital markets. I have had a long history and specialization with concentrated positions and options trading. Made money in 2008 with a net long portfolio, deploying capital in some of the market's darkest hours into long positions including purchases of American Express, Atlas Energy, Crosstex, First Industrial Real Estate, General Growth Properties, Genworth, Macquarie Infrastructure, Ruth Chris Steakhouse, and Vornado near their lows. Shorting, hedging, and option strategies also helped me in 2007 and 2009, and these are skills that I have developed ever since I started trading heavily in 1996.I enjoy reading, accumulating knowledge, and putting this knowledge to work in the active capital markets, learning lessons along the way.To this day, I continue to learn, and some of these learning lessons have been excruciatingly difficult ones, especially over the past several years, as I made mistakes allocating capital, including a sizable portion of my own capital (I always invest alongside my clients), to commodity related stocks. While all commodity related stocks have struggled since April of 2011, coal companies, which attracted me due to their extremely cheap valuations, and out-of-favor status (I am a strong believer in behavioral finance alongside fundamentals and technicals) have been the worst investing mistake of my career. The focus on the commodity arena has been the biggest mistake of my investment career thus far, yet in its aftermath, I see tremendous opportunity, even larger in scope than the fortuitous 2008/2009 environment.The capital that I accumulated and the confidence gained in navigating the treacherous investment waters of 2008 gave me the confidence to launch my own investment firm in the spring of 2009, right before the ultimate lows in the stock market. At the time I was working as a senior analyst at one of the largest RIA's in the country, and I felt strongly that the market environment was the best time since 1974/1975 to start an investment firm.
Prior to starting my firm, I was a senior analyst for three different firms over approximately 10 years (Charles Schwab, Redwood, Oxford), moving up in responsibility and scope at each stop along my journey. Since I was a paperboy, I have always had an interest in the investment markets. I love researching and finding opportunities. I am a Chartered Financial Analyst, CFA, as well as a Chartered Alternative Investment Analyst, CAIA. After starting in the teaching program at Ball State University, I switched to a career in finance when I turned a small student loan into a substantial amount of capital. I graduated summa cum laude with a degree in finance from Ball State.
Full disclosure, I am not currently a registered investment advisor, though I did serve in this capacity from 2009-2014, while owning Koldus Contrarian Investments, Ltd. Additionally, I held various securities licenses from 2000-2014, without a single complaint filed, and I continue to hold industry designations. At the end of 2014, I voluntarily let my state registration expire, as I transitioned the business to a different structure. At the time, I was in the midst of a difficult two-year plus divorce (my ex-wife left for another relationship) and custody battle, which occupied a lot of my time. Prior to this, I had passed, and held, various securities exams and licenses, including the Series 7, Series 63, and Series 65 exams, in addition to others, alongside my CFA and CAIA designations. Unfortunately, I did not file the proper paperwork to withdraw my state registration, and I did not disclose a personal arrangement, and subsequent civil case, between myself and a former close personal friend and client, that was initiated in 2011. I was unaware that I was required to disclose these items, and my securities attorney, at the time, did not advise me to do so. Previously, I had managed a portfolio for this gentleman, and we had taken an investment of approximately $7 million in 2009, and grown it to over $25 million at the beginning of 2012. After a difficult year of performance, an employee of the firm I owned, and friend, resigned in early 2013, and took the aforementioned client to a competing firm. As a result of not filing the proper paperwork, I agreed to a settlement, with a potential $2500 fine in the future, depending on if I choose to reapply to be a non-exempt advisor.
I am an early career scientific researcher who has taken a strong interest in investing, both for achieving my personal financial goals as well as serving as an alternative conduit where critical and logical thinking are appreciated and rewarded. I write articles to share ideas, refine my own thinking and invite discussion from the astute readership of Seeking Alpha.
For a better Seeking Alpha experience on your phone, please consider viewing the website on your browser (request desktop site for full functionality) instead of through the Seeking Alpha app.
Within the academic field, I have a career total of 87 articles and 5 book chapters, 2,600 total citations and an h-index of 31 (metrics from Google Scholar).
Bay Area Biotech is a group of self-organized life science graduate/medical/business students and postdoctoral scholars who are interested in utilizing our scientific training to evaluate biotechnologies and identify investment opportunities. Opinions published here are those of the authors.
If you are interested in any of my digital utility solutions to add to your investing tool box to improve your investment outcomes, please visit my site
You'll find elegant applications that make it simple for you to track your portfolio in real time, make a watch list to follow in real time, track your dividend income and growth, and other applications. These applications will allow you to set alerts at prices you choose in order to obtain the yield and income that you want. They function as real time trade assistants and will improve your investment performance. You can even mirror the successful FTG Portfolio with "My FTG Mirror Calculator", and subscribers can mirror the premium subscriber portfolio with "MY RODAT Mirror Calculator" if they wish to emulate the out performance we've achieved in capital and income growth.
I am a retired clinical psychologist, and administrator and owner of a rehabilitation clinic we founded 40 years ago. For over 55 years I have managed several portfolios composed of investments accumulated over our professional careers. Since the financial crisis of 2008, I have employed specialized, customized dividend growth strategies aimed at enhancing and growing a dividend income stream.
Since December 24, 2014, I have demonstrated on Seeking Alpha the ongoing construction and portfolio management of the Fill-The-Gap Portfolio aimed at highlighting strategies investors may utilize to close the gap between an average Social Security benefit and the much greater costs faced in retirement.
This portfolio has outperformed all of the broad market indexes by a very wide margin, growing dividend income and total portfolio value consistently while the broader indexes struggle in negative territory all year.
Aside from free articles available to the general public, additional early-access, value-added ideas and deep-dive articles are offered to paid subscribers on my premium SA platform, "Retirement: One Dividend At A Time"
Let me show you how to build and grow your portfolio and dividend income, step by step, towards a comfortable and secure retirement.
Peter Way Associates is the only known provider of the price range forecasts of widely-held, actively traded stocks derived from the hedging activities of market-making [MM] firms as they balance big-$-fund sellers and buyers in large block trades. The price ranges offer explicit downside exposure forecasts not commonly found in publicly published investment analyses.
This is all forward-looking data, based on what the MMs will pay for protection against coming unwanted price change while temporarily committed firm capital is exposed to market risks. It is available by modest subscription cost at blockdesk.com.
The behavioral analysis involved has been performed daily since Y2K, now on over 3,000 stocks, ETFs, and market indexes. That has built an actuarial history of how market prices have subsequently behaved following several million price range forecasts, issue by issue.
That data provides a qualitative backdrop to current forecasts in terms of odds of profitable positions, size of prospective gains, credibility of forecasts, and worst-case price drawdown exposure experiences.
Peter F. Way is a veteran Chartered Financial Analyst, having taken and passed the CFA Institute’s required 3 examinations in the first years they were given, 40+ years ago.
Armed with BS in Economics from the Wharton School and an MBA degree from Harvard Business School, he has managed staffs of dozens of Investment Researchers and Quantitative Analysts for the nation’s largest bank, arbitraged index options for NYSE Specialists, and managed portfolios of hundred-million-dollar equity investments for Fortune 100 corporate pension funds and non-profit endowments.
He has been elected President of professional Investment Analyst Societies in San Diego and New York City and has served on the editorial boards of the Financial Analysts Journal and the CFA Digest. He has spoken at numerous schools and professional meetings.
Mr. Leach spent his early years on a subsistence farm in western Michigan. He graduated at the top of his high school class which helped him land a scholarship to the University Michigan. Graduating magna cum laude with a bachelor’s degree in Nuclear Engineering and a minor in mathematics in 1981, Mr. Leach took his first professional job with Westinghouse Electric in Monroeville, PA.
Mr. Leach held several positions of increasing responsibility at Westinghouse, and Fluor Federal Services in Pennsylvania, South Carolina, and Washington State. While in Washington State, Mr. Leach completed his master’s of science degree in Environmental Engineering graduating summa cum laude in 1997 from Washington State University.
In 2003 and 2004 with Fluor Federal Services, Mr. Leach worked as a civilian contractor for the US Department of Defense in various middle east locations and the Philippines. In 2005, Mr. Leach joined the AREVA Group and spent two years in France. After returning stateside in 2006, Mr. Leach held various positions of increasing responsibility with AREVA Federal Services in South Carolina and North Carolina. Mr. Leach left the AREVA group in 2014 at the age of 56 and is now quasi-retired and focuses on his wife, his 15 year old son, and his investment portfolio.
Mr. Leach has been a consistent, avid, and successful investor for more than 30 years. His investment style is conservative and he primarily invests in income oriented equities, bonds, preferred stocks and mutual funds. Mr. Leach has written more than 50 articles on Seeking Alpha and other websites.
A veteran of the pharma industry. Specializing in the analysis of small pharma companies with a focus on the pipeline and opportunities for licensing or major deals with large pharma. Financial analysis including burn rate, venture capital funding, and cash flow.
Chris DeMuth Jr. is the founder of Rangeley Capital LLC. Rangeley is an investment firm that focuses on event driven, value-oriented investment opportunities. Rangeley Capital and his value investing forum, Sifting the World (StW), search the world for misplaced bets. Rangeley exploits them for its investors and then Mr. DeMuth writes about them on StW.
MY WINNING RATIO on SA is 9/10 HISTORICALLY. Check my comments to verify.
------------------------------------------------------------------------------------------------------- I have been short and long stocks for 20 years as a fund mgr.
I am a swing style trader. Not an analyst nor an economist.
Its not about being right. Its about being profitable.
Over 30 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
I am an independent equity research analyst and consultant. I focus on finding small-cap biotech stocks where I believe there is favorable risk / reward because of misinformation, lack of information, or a potential fundamental turnaround. I provide detail analysis for investors and investor relations companies. I also provide due diligence and advisory services to companies. Some names I write on I invest in personally and will disclose my position. Names that have hired me to provide due diligence or advisory services I will disclose a business relationship. I previously worked for Zacks Investment Research from 2003 to 2015 as a Senior Biotechnology Analyst. Prior to Zacks, I spent 1999 to 2002 managing money with Eastover Capital in Charlotte, NC where I focused on large-cap equities, specializing in healthcare, energy, and technology. Prior to joining Eastover, I worked as a research scientist for TechLab, Inc., a biotechnology company focused on developing diagnostic kits and vaccines for infectious diseases, between 1995 and 1998. I also spent a year working at the Fralin Biotechnology Center, and a year working for a cancer researcher while at Virginia Tech. I have a B.S. in Biochemistry from Virginia Tech, with a B.A in Chemistry and a minor in Math. I have a M.B.A. in Finance, with a concentration in Securities Analysis, from Wake Forest University. I hold the Chartered Financial Analyst (CFA) designation.
Stay tuned for a series of "charting 101" videos in an attempt to get the beginners foot in the door, and to provide further guidance for continued education on your own!
Basic technical analysis videos for the masses to begin to learn how to use charts to stay one step ahead of the herd. I have been a full time traveler and trader for four years, taught by some very generous strangers (at the time) and I am on a quest to pay that knowledge forward. There is no better gift than financial freedom, start working towards yours today!
I encourage questions, requests, and suggestions!
My name is Dr Kanak Kanti De, MBBS, MD, PhD, retired medical practitioner, cancer survivor, healthcare sector investor, over 30 years' experience in the sector both in India and the United States. I write/have written on Motley Fool, SeekingAlpha, Benzinga, and on Forbes. I am consistently ranked high on TipRanks, although I don't like their ranking system. My portfolio has consistently beat the various indices for years. Email me to discuss my articles, or for just an adda (Bengali for informal chat) firstname.lastname@example.org.
Quote: "It is well enough that people of our American nation do not understand our banking and monetary system, for if they did, I believe there would be a revolution before tomorrow morning."
Disclaimer: My articles and comments do not contain investment recommendations or personal investment advice to any specific person for any particular purpose. Any article or comment is not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action. Do your own research or obtain suitable personal advice. You are responsible for your own investment decisions. Any information I publish is not a recommendation or solicitation to buy or sell securities, nor am I a registered investment advisor. Investing carries risk of loss and is not suitable for all individuals.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
An experienced research and advisory team of Traders and Forecasters have combined to offer free services and alerts at StockReversals.com, A free growth stock profile, research and alert service with benefits. Go to the website to subscribe for free. We also offer StockReversalsPremium.com which offers a combination of long term growth stock profiles with massive upside potential, plus swing position trading (days to 8 weeks holding).
Seeking Alpha Certified and Frequent Contributor to numerous financial websites. We specialize in behavioral analysis as it applies to market patterns and reversal trends. These trends happen over short term, intermediate, and long term time frames. We help our free subscribers with Business Disruptor growth stocks that crush the market. Sample picks include FB, YY, DATA, INVN, SPCB, MOBI, CUR and many more. In 6 months we had 6 doubles, 1 triple, and 16 of 19 companies up 30-50% or more.
Our work centers around a combination of Elliott Wave Theory, Technical Analysis, Human Behaviors, Sentiment, and Business Disruption analysis.
We have advisory clients from around the world. South Korea, Australia, Canada, Sweden, Germany, The Netherlands and of course the U.S.
We give away our service for free because of the laws of nature which we have on our website:
“The possession of knowledge, unless accompanied by the manifestation and expression in sharing is a vain and foolish thing. The Law of Use is universal, and he who violates it suffers by reason of his conflict with natural forces.”
Join us today at stockreversals.com and sign up for free.
I joined Seeking Alpha in February 2014 as editor of the biotech vertical. In addition to onboarding new contributors, my job is to make sure Seeking Alpha provides high-quality and comprehensive coverage of the biotechnology and health care sectors. I am always looking for new ideas, so please reach out if you're interested.
I am an analyst and Level II Candidate in the CFA Program that has gained experience in the investment industry through positions as a proprietary trader and a portfolio management administrator. I began contributing to Seeking Alpha as a way to share my thoughts on the biopharmaceutical industry. I discussed ways to minimize risk in biopharmaceutical investing through conservative pipeline valuation and balance sheet analysis to identify companies presenting a compelling valuation to potential investors. I also touched on ways to apply knowledge of the markets to improve personal finance. My pieces included either stock-specific analysis or general biopharmaceutical investing discussion through my Biotech Weekly blog. My research appeared on the websites of CNBC, Seeking Alpha, Reuters, Google Finance, Morningstar, NASDAQ, and MarketWatch.
Note: Articles and comments are my own opinions, are not related to the opinions of my employer, and should not be considered investment advice. Make sure to do your own due diligence before making an investment decision. Thanks!
I was first interested in stocks and investing while in High School. With my first job I saved a significant portion of that and put it into various instruments i.e. Roth IRA and stocks mostly. I started college for Business Administration and continued teaching myself principles of investing and savings and good personal finance. I graduated with an MBA in Financial Planning from California Lutheran University in May of 2011.
I have not worked in any capacity as a financial analyst but have significant experience in stock analysis mainly using fundamental methods but have recently started using technical analysis as well. A significant portion of my free time is spent with this hobby and I have a lot at stake as I have been investing roughly 40% of my salary for the last 16 years. I have a significant nest egg at the moment and hope to be partially retired within 5 years by 2019. I have been building a property rental and investment business and continue to build that and expand that.
What does the future bring for me? I hope to continue building and growing my business as well as publish articles on investing and start a blog in the future as well.
I added stock and bond analysis to my IT consulting business at the request of a small cap investment specialist in 2002. For my own account I invest mainly in technology and biotechnology stocks, but occasionally I invest in industrial, retail and other stocks. My technology and investment web site is openicon.com. I still enjoy IT consulting and always have some sort of R&D project going on.
I am currently an individual investor with focus on event-driven trading and long-short opportunities. I graduated Emory University in 2009 and am also a finance Phd dropout from UCLA Anderson. I could be reached at email@example.com
My husband plans to retire in 4 years (at age 67) and I plan to retire in 7 years (at age 62). We began focusing on dividend growth investing in 2013 but have been invested in mutual funds for decades. Our current DGI retirement portfolio is comprised of the following 64 DGI stocks: ABBV, ABT, AMGN, AVA, BBL, BMY, CAT, CBRL, CCP, CLX, CMCSA, COP, CVX, D, DEO, DLR, DUK, ED, EMR, EPD, GAS, GE, GILD, GIS, HCP, IBM, JNJ, KHC, KMB, KMI, KO, LMT, LNT, MCD, MMM, MMP, MO, MRK, MSFT, NEE, NOK, O, OHI, OMI, PEP, PFE, PG, PM, SCG, SEP, SO, SYY, T, TUP, UL, UPS, VTR, VZ, WEC, WMT, WPC, XEL, XOM, and ZBH.